Andreas Mathy – GF – Mathy Holding Gmbh

About Us

Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection

Star oct 17 13 by Mid-America Publishing Corporation - Issuu

18th European Symposium on Radiopharmacy and Radiopharmaceuticals, EJNMMI Radiopharmacy and Chemistry

Google Glass #ifihadglass Winners

COVID-19: Drug Targets and Potential Treatments

Mathy Holding GmbH, Linz, Austria

Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19

NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings. - Abstract - Europe PMC